Trials / Recruiting
RecruitingNCT03512132
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
A number of arguments suggest that the deterioration in high density lipoproteins (HDL) functioning may worsen with the development of nephropathy during type 1 diabetes (T1D). The objective of this study will be to investigate to what extent nephropathy in T1D patients in the microalbuminuria and macroalbuminuria stages, compared to T1D patients without nephropathy, is associated with an alteration in HDL functionality and changes in HDL size and composition (lipids with detailed study of phosphates and sphingolipids, main lipoproteins, inflammatory markers).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood samples | 5 EDTA tubes of 7ml and 1 dry tube of 7 ml taken on an empty stomach |
| BIOLOGICAL | Urine sample | Urine sample on an empty stomach |
Timeline
- Start date
- 2018-04-24
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2018-04-30
- Last updated
- 2024-07-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03512132. Inclusion in this directory is not an endorsement.